| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Immuneering Corporation Class A Common Stock (NASDAQ: IMRX)
IMRX Technical Analysis
2
| As on 9th Jun 2023 IMRX STOCK Price closed @ 9.90 and we RECOMMEND Buy for LONG-TERM with Stoploss of 8.87 & Strong Sell for SHORT-TERM with Stoploss of 12.96 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMRXSTOCK Price
| Open | 10.39 | Change | Price | % |
| High | 10.84 | 1 Day | -0.36 | -3.51 |
| Low | 9.75 | 1 Week | 3.41 | 52.54 |
| Close | 9.90 | 1 Month | -0.24 | -2.37 |
| Volume | 63200 | 1 Year | -11.43 | -53.59 |
| 52 Week High 23.03 | 52 Week Low 3.78 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IMRX Daily Charts |
IMRX Intraday Charts |
Whats New @ Bazaartrend |
IMRX Free Analysis |
|
|
IMRX Important Levels Intraday
| RESISTANCE | 12.00 |
| RESISTANCE | 11.33 |
| RESISTANCE | 10.91 |
| RESISTANCE | 10.49 |
| SUPPORT | 9.31 |
| SUPPORT | 8.89 |
| SUPPORT | 8.47 |
| SUPPORT | 7.80 |
IMRX Forecast May 2024
| 4th UP Forecast | 25.89 |
| 3rd UP Forecast | 20.76 |
| 2nd UP Forecast | 17.59 |
| 1st UP Forecast | 14.42 |
| 1st DOWN Forecast | 5.38 |
| 2nd DOWN Forecast | 2.21 |
| 3rd DOWN Forecast | -0.96 |
| 4th DOWN Forecast | -6.09 |
IMRX Weekly Forecast
| 4th UP Forecast | 24.55 |
| 3rd UP Forecast | 19.85 |
| 2nd UP Forecast | 16.95 |
| 1st UP Forecast | 14.04 |
| 1st DOWN Forecast | 5.76 |
| 2nd DOWN Forecast | 2.85 |
| 3rd DOWN Forecast | -0.05 |
| 4th DOWN Forecast | -4.75 |
IMRX Forecast2024
| 4th UP Forecast | 48.38 |
| 3rd UP Forecast | 36.04 |
| 2nd UP Forecast | 28.41 |
| 1st UP Forecast | 20.78 |
| 1st DOWN Forecast | -0.98 |
| 2nd DOWN Forecast | -8.61 |
| 3rd DOWN Forecast | -16.24 |
| 4th DOWN Forecast | -28.58 |
Immuneering Corporation Class A Common Stock ( NASDAQ USA Symbol : IMRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMRX Business Profile
Immuneering Corporation is a biopharmaceutical company with a pipeline focusing on improving patient outcomes across a spectrum of oncologic and neurologic diseases by applying its bioinformatics to every stage of the drug development process. It provides bioinformatics and generates insights into drug mechanisms of action and patient treatment responses. The company was incorporated in 2008 and is based in Cambridge, Massachusetts. Address: 245 Main Street, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service